Columbia, MO6 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Columbia, MO

Find 6 actively recruiting myalgic encephalomyelitis clinical trials in Columbia, MO. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
604
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Columbia

About Myalgic Encephalomyelitis Clinical Trials in Columbia

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 6 myalgic encephalomyelitis clinical trials recruiting participants in Columbia, MO. These studies are seeking a combined 604 participants. Research is being sponsored by Takeda, University of Missouri-Columbia, Akeso and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Columbia — FAQ

Are there myalgic encephalomyelitis clinical trials in Columbia?

Yes, there are 6 myalgic encephalomyelitis clinical trials currently recruiting in Columbia, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.

Are clinical trials in Columbia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 6 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated September 2, 2026 from ClinicalTrials.gov